In a recent study, we demonstrated that knocking down TRPV4 in colon cancer cells suppressed their malignant potential by activating PTEN, and decreased their invasiveness via inhibition of ZEB1 signaling (Liu et al., 2019; Zhang et al., 2021). This evidence concerns the gene ZEB1 and colonic neoplasm.